Evaluating the Utility of Self and Clinical Skin Examinations to Screen for Skin Cancer: The Importance of Considering Publications of All Levels of Evidence

Main Article Content

Ryan M Svoboda
National Society for Cutaneous Medicine, New York, NY

Clay J Cockerell
Roger I Ceilley
Darrell S Rigel

Keywords

skin exam, skin cancer, screening, USPSTF

Abstract

No Abstract Available

References

1. United States Preventative Services Task Force. Screening for skin cancer: US preventive services task force recommendation statement. JAMA. 2016;316(4):429-435.

2. Grossman DC, Curry SJ, Owens DK, et al. Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(11):1134-1142.

3. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA. 1992;268(17):2420-2425.

4. Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL. Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst. 1996;88(1):17-23.

5. Smith GC, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ (Clinical research ed). 2003;327(7429):1459-1461.

Article Sidebar

Full Article PDF
Published
Apr 30, 2018
DOI https://doi.org/10.25251/skin.2.3.4

Article Details

How to Cite
Svoboda, R. M., Cockerell, C. J., Ceilley, R. I., & Rigel, D. S. (2018). Evaluating the Utility of Self and Clinical Skin Examinations to Screen for Skin Cancer: The Importance of Considering Publications of All Levels of Evidence. SKIN The Journal of Cutaneous Medicine, 2(3), 172–174. https://doi.org/10.25251/skin.2.3.4
Issue
Vol. 2 No. 3 (2018)
Section
Special Section on Skin Cancer
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

1 2 3 > >>